Therapieallergene zur spezifischen Immuntherapie: Zulassung und Qualitätskriterien aus der Sicht des Paul-Ehrlich-Instituts

Author: May S.   Kaul S.   Schröder C.   Vieths S.  

Publisher: Springer Publishing Company

ISSN: 0017-8470

Source: Der Hautarzt, Vol.57, Iss.10, 2006-10, pp. : 867-874

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next